1. Clinical & Scientific Overview
Adrenaline (Epinephrine) Tartrate IP [Supplementary Emergency Module App-B.1] (TIP-MED-000445, Reference Code [12.32]-CMP175) is classified under
Vaccines, Immunologicals & Emergency Toxicology Antidotes (Ch 12) as a Competitive Muscarinic Acetylcholine Receptor Antagonist (Anticholinergic Antidote & Vagolytic).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Co-indexed per approved Author Decision DEC-01 (Option 1A; preserved in IP_Supplementary_Emergency_Module_App_B_1.json [App-B.1]). 1:1000 (0.3–0.5 mg IM anterolateral thigh) for anaphylaxis; 1:10,000 (1 mg [10 mL] IV push) for cardiac arrest.
Standard approved strengths (refer to comparative context)
3. Mechanism of Action & Pharmacodynamics
Co-indexed per approved Author Decision DEC-01 (Option 1A; preserved in IP_Supplementary_Emergency_Module_App_B_1.json [App-B.1]). 1:1000 (0.3–0.5 mg IM anterolateral thigh) for anaphylaxis; 1:10,000 (1 mg [10 mL] IV push) for cardiac arrest.
4. Therapeutic Indications & Evidence-Supported Uses
- First-line life-saving antidote in organophosphate (OP) and carbamate insecticide poisoning
- symptomatic sinus bradycardia / AV nodal block
- pre-anaesthetic antisialagogue
- coadministration with Neostigmine in neuromuscular reversal
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Co-indexed per approved Author Decision DEC-01 (Option 1A; preserved in IP_Supplementary_Emergency_Module_App_B_1.json [App-B.1]). 1:1000 (0.3–0.5 mg IM anterolateral thigh) for anaphylaxis; 1:10,000 (1 mg [10 mL] IV push) for cardiac arrest.
Administration & Meal Timing: See Administration & Counselling below. | Standard clinical schedule per indication.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Comparative pharmacokinetic profile co-indexed under [12.32].
Renal: No adjustment in emergency resuscitation/poisoning. • Hepatic: No adjustment in emergency resuscitation/poisoning.
Renal: No adjustment in emergency resuscitation/poisoning. • Hepatic: No adjustment in emergency resuscitation/poisoning.
Renal: No adjustment in emergency resuscitation/poisoning. • Hepatic: No adjustment in emergency resuscitation/poisoning.
7. Contraindications, Precautions & High-Risk Warnings
- Contraindications: No absolute contraindications in life-threatening bradycardia or OP poisoning. Routine use contraindicated in narrow-angle glaucoma, myasthenia gravis (unless reversing cholinergic crisis), paralytic ileus, pyloric stenosis. • Precautions: CRITICAL INDIAN OP POISONING PEARLS: (1) The endpoint of Atropine titration in OP poisoning is a DRY CHEST (absence of bronchorrhoea/wheeze) and adequate haemodynamics—NOT pupil dilation (mydriasis lags behind or may not occur if ocular exposure occurred); (2) Correct hypoxia BEFORE or alongside the first Atropine bolus if possible to reduce ventricular fibrillation risk, but never delay Atropine in drowning-in-secretions bronchorrhoea; (3) In heart transplant recipients (denervated heart), Atropine is ineffective or causes paradoxical AV block.
Key Clinical Precautions: Renal: No adjustment in emergency resuscitation/poisoning. • Hepatic: No adjustment in emergency resuscitation/poisoning.
8. Adverse Effects Profile
- Dry mouth, blurred vision, photophobia, flushing, tachycardia, urinary retention, constipation.
- Atropine toxicity/delirium ('blind as a bat, mad as a hatter, red as a beet, hot as a hare, dry as a bone'), hyperthermia, ventricular tachyarrhythmias, acute angle-closure glaucoma.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Antihistamines / TCAs / Phenothiazines -> additive anticholinergic delirium; Potassium chloride wax-matrix tablets -> GI ulceration due to delayed transit
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent class monograph [12.32].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: For 1% Atropine eye drops: blurring of near vision and pupil dilation last for 7–14 days.
- Meal & Clock Timing Instruction: See Administration & Counselling below. (Standard clinical schedule per indication.)
- Missed Dose Protocol: Take as soon as remembered unless close to next scheduled dose; never double the dose.
- Geriatric Dispensing Pearl: Schedule: Schedule H | NLEM 2022: Yes | Compendia: IP 2026 / NFI 7th Ed 2026 / NLEM 2022 / CDSCO Schedule H / BNF 90th Ed
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Injection: 0.6 mg/mL (1 mL ampoule); High-Strength OP Poisoning Vial: 1 mg/mL (30 mL / 100 mL vial); Ophthalmic Drops/Ointment: 1% w/v.
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [12.35]-C178 Rabies mAb — Inactivated Cell-Culture Rabies Vaccine (Active Immunisation) & P
- [12.36]-C179 Diphtheria Toxoid (Td) — Adsorbed Bacterial Toxoid Vaccine (Active Immunisation against Cl
- [12.36]-C180 Adsorbed Tetanus Toxoid (TT) — Adsorbed Bacterial Toxoid Vaccine (Active Immunisation against Cl
- [12.31] Naloxone Hydrochloride (Parenteral Opioid Overdose Antidote) — Pure Competitive Opioid Receptor Antagonist (Mu, Kappa & Delta An